Skip to Main content Skip to Navigation
Journal articles

Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort

Anne Fages 1, 2 Talita Duarte-Salles 3 Magdalena Stepien 3 Pietro Ferrari 4, 3 Veronika Fedirko 5 Clément Pontoizeau 2 Antonia Trichopoulou 6 Krasimira Aleksandrova 7 Anne Tjønneland 8 Anja Olsen 9 Françoise Clavel-Chapelon 10 Marie-Christine Boutron-Ruault 10, 11 Gianluca Severi 12 Rudolf Kaaks 13 Tilman Kuhn 14 Anna Floegel 15 Heiner Boeing 16 Pagona Lagiou 6, 17 Christina Bamia 18 Dimitrios Trichopoulos 6 Domenico Palli 19 Valeria Pala 20 Salvatore Panico 21 Rosario Tumino 22 Paolo Vineis 23 H. Bas Bueno-De-Mesquita 24 Petra H. Peeters 25, 26 Elisabete Weiderpass 27, 28, 29 Antonio Agudo 30 Esther Molina-Montes 31, 32 José María Huerta 33, 34 Eva Ardanaz 32, 35 Miren Dorronsoro 36 Klas Sjöberg 37 Bodil Ohlsson 38 Kay-Tee Khaw 39 Nick Wareham 40 Ruth C. Travis 41 Julie A. Schmidt 42 Amanda Cross 43 Marc Gunter 44 Elio Riboli 45 Augustin Scalbert 46 Isabelle Romieu 47 Benedicte Elena-Herrmann 1 Mazda Jenab 5
2 ISA - Centre de RMN à très hauts champs (2011-2018)
ISA - Institut des Sciences Analytiques
37 Volvo
Abstract : Background: Hepatocellular carcinoma (HCC), the most prevalent form of liver cancer, is difficult to diagnose and has limited treatment options with a low survival rate. Aside from a few key risk factors, such as hepatitis, high alcohol consumption, smoking, obesity, and diabetes, there is incomplete etiologic understanding of the disease and little progress in identification of early risk biomarkers. Methods: To address these aspects, an untargeted nuclear magnetic resonance metabolomic approach was applied to pre-diagnostic serum samples obtained from first incident, primary HCC cases (n = 114) and matched controls (n = 222) identified from amongst the participants of a large European prospective cohort. Results: A metabolic pattern associated with HCC risk comprised of perturbations in fatty acid oxidation and amino acid, lipid, and carbohydrate metabolism was observed. Sixteen metabolites of either endogenous or exogenous origin were found to be significantly associated with HCC risk. The influence of hepatitis infection and potential liver damage was assessed, and further analyses were made to distinguish patterns of early or later diagnosis. Conclusion: Our results show clear metabolic alterations from early stages of HCC development with application for better etiologic understanding, prevention, and early detection of this increasingly common cancer.
Complete list of metadatas

Cited literature [66 references]  Display  Hide  Download
Contributor : Agnès Bussy <>
Submitted on : Monday, December 9, 2019 - 4:42:21 PM
Last modification on : Sunday, October 25, 2020 - 7:06:28 AM
Long-term archiving on: : Tuesday, March 10, 2020 - 10:05:11 PM


Publication funded by an institution


Distributed under a Creative Commons Attribution 4.0 International License



Anne Fages, Talita Duarte-Salles, Magdalena Stepien, Pietro Ferrari, Veronika Fedirko, et al.. Metabolomic profiles of hepatocellular carcinoma in a European prospective cohort. BMC Medicine, BioMed Central, 2015, 13 (242), ⟨10.1186/s12916-015-0462-9⟩. ⟨hal-01234339⟩



Record views


Files downloads